Prathyusha Durabaibu
Fortuna: 614 639 $ al 31/05/2026
Fortuna: 614 639 $ al 31/05/2026
Prathyusha Durabaibu is currently an Independent Director at Organogenesis Holdings, Inc. since 2021.
Formerly, Ms. Durabaibu was Controller at Pacific Biosciences of California, Inc. from 2010 to 2019 and Principal Financial Officer at Sangamo Therapeutics, Inc. from 2025 to 2026.
Education includes an undergraduate degree from Oxford Brookes University and an MBA from San Jose State University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 10/04/2026 | 198.219 ( 0,15 % ) | 509 423 $ | 31/05/2026 | |
| 22/01/2026 | 482.645 ( 0,12 % ) | 105 217 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ORGANOGENESIS HOLDINGS INC. | Director/Miembro de la Junta | 19/11/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Director Financiero/CFO | 03/02/2026 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Comptroller/Controller/Auditor | 01/03/2019 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures sequencing system products to help scientists to resolve genetically complex problems | Health Technology |
Oxford Brookes University
Oxford Brookes University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
San Jose State University
San Jose State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Organogenesis Holdings, Inc.
Organogenesis Holdings, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes regenerative medicines products for the advanced wound care and surgical and sports medicine markets | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.